The European Medicines Agency is seeking feedback on a modernized version of a 19-year-old guideline on good clinical practice (GCP) that has been updated to factor in improved and more efficient approaches to clinical trial design, conduct, oversight, recording and reporting1,2.
The update is in the form of an addendum to the International Conference on Harmonisation E6 (R2) guideline on GCP,...




